Rank | Gene Set | Z-score |
---|---|---|
1 | pyrimidine nucleobase catabolic process (GO:0006208) | 6.99579152 |
2 | nucleobase catabolic process (GO:0046113) | 5.41021458 |
3 | neuron cell-cell adhesion (GO:0007158) | 5.40721151 |
4 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.34535048 |
5 | locomotory exploration behavior (GO:0035641) | 5.05199075 |
6 | vocalization behavior (GO:0071625) | 4.99765083 |
7 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.87118152 |
8 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.76097015 |
9 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.72011705 |
10 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 4.54745392 |
11 | protein localization to synapse (GO:0035418) | 4.54140400 |
12 | synaptic vesicle exocytosis (GO:0016079) | 4.53282400 |
13 | presynaptic membrane assembly (GO:0097105) | 4.48574905 |
14 | glutamate receptor signaling pathway (GO:0007215) | 4.41491374 |
15 | neuron-neuron synaptic transmission (GO:0007270) | 4.31983687 |
16 | gamma-aminobutyric acid transport (GO:0015812) | 4.31814153 |
17 | response to histamine (GO:0034776) | 4.28732833 |
18 | positive regulation of mitochondrial fission (GO:0090141) | 4.27167473 |
19 | exploration behavior (GO:0035640) | 4.26048105 |
20 | glutamate secretion (GO:0014047) | 4.23948176 |
21 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.22485192 |
22 | behavioral response to cocaine (GO:0048148) | 4.20992351 |
23 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.19932564 |
24 | neurotransmitter secretion (GO:0007269) | 4.16467848 |
25 | neuron recognition (GO:0008038) | 4.16172315 |
26 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.13104653 |
27 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 4.13083423 |
28 | synaptic transmission, glutamatergic (GO:0035249) | 4.12710033 |
29 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.10050597 |
30 | presynaptic membrane organization (GO:0097090) | 4.08903809 |
31 | * calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 4.05335275 |
32 | establishment of mitochondrion localization (GO:0051654) | 4.04396825 |
33 | synaptic vesicle maturation (GO:0016188) | 4.03230865 |
34 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.91723706 |
35 | prepulse inhibition (GO:0060134) | 3.90078064 |
36 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.89625234 |
37 | long-term synaptic potentiation (GO:0060291) | 3.85325849 |
38 | postsynaptic membrane organization (GO:0001941) | 3.85210469 |
39 | retinal ganglion cell axon guidance (GO:0031290) | 3.80587106 |
40 | axonal fasciculation (GO:0007413) | 3.79956997 |
41 | transmission of nerve impulse (GO:0019226) | 3.77058114 |
42 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.72188273 |
43 | neuronal action potential propagation (GO:0019227) | 3.71372815 |
44 | nonmotile primary cilium assembly (GO:0035058) | 3.70047805 |
45 | regulation of synaptic vesicle transport (GO:1902803) | 3.67085122 |
46 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.66812183 |
47 | layer formation in cerebral cortex (GO:0021819) | 3.65319236 |
48 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.64508467 |
49 | cerebellar granule cell differentiation (GO:0021707) | 3.59573559 |
50 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.58903649 |
51 | striatum development (GO:0021756) | 3.52522976 |
52 | behavioral response to nicotine (GO:0035095) | 3.52356604 |
53 | dendritic spine morphogenesis (GO:0060997) | 3.50170254 |
54 | regulation of postsynaptic membrane potential (GO:0060078) | 3.47480178 |
55 | positive regulation of synapse maturation (GO:0090129) | 3.47145445 |
56 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 3.45226437 |
57 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 3.45226437 |
58 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 3.43475518 |
59 | intraciliary transport (GO:0042073) | 3.40283787 |
60 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.36035803 |
61 | limb bud formation (GO:0060174) | 3.35858384 |
62 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.35768544 |
63 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.31890928 |
64 | olfactory bulb development (GO:0021772) | 3.27975379 |
65 | regulation of neurotransmitter uptake (GO:0051580) | 3.27902581 |
66 | negative regulation of oligodendrocyte differentiation (GO:0048715) | 3.26851070 |
67 | learning (GO:0007612) | 3.26778521 |
68 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 3.24989492 |
69 | innervation (GO:0060384) | 3.24492082 |
70 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.24441937 |
71 | startle response (GO:0001964) | 3.23690412 |
72 | regulation of synapse structural plasticity (GO:0051823) | 3.23194968 |
73 | regulation of synaptic plasticity (GO:0048167) | 3.22111199 |
74 | positive regulation of membrane potential (GO:0045838) | 3.21539726 |
75 | axon extension involved in axon guidance (GO:0048846) | 3.20107504 |
76 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 3.20107504 |
77 | neurotransmitter transport (GO:0006836) | 3.19799826 |
78 | sequestering of actin monomers (GO:0042989) | 3.19549555 |
79 | spinal cord association neuron differentiation (GO:0021527) | 3.19030340 |
80 | dendrite morphogenesis (GO:0048813) | 3.18545719 |
81 | forebrain neuron differentiation (GO:0021879) | 3.17154577 |
82 | proline transport (GO:0015824) | 3.15760227 |
83 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.15746469 |
84 | dendrite development (GO:0016358) | 3.15208198 |
85 | * synapse assembly (GO:0007416) | 3.14190396 |
86 | head development (GO:0060322) | 3.12616480 |
87 | synaptic vesicle endocytosis (GO:0048488) | 3.11712919 |
88 | negative regulation of neurotransmitter transport (GO:0051589) | 3.11610583 |
89 | behavioral fear response (GO:0001662) | 3.11448500 |
90 | behavioral defense response (GO:0002209) | 3.11448500 |
91 | activation of protein kinase A activity (GO:0034199) | 3.10418667 |
92 | long-term memory (GO:0007616) | 3.06105885 |
93 | positive regulation of synapse assembly (GO:0051965) | 3.02003292 |
94 | membrane hyperpolarization (GO:0060081) | 3.01988266 |
95 | regulation of neurotransmitter levels (GO:0001505) | 3.00368341 |
96 | intraspecies interaction between organisms (GO:0051703) | 3.00030567 |
97 | social behavior (GO:0035176) | 3.00030567 |
98 | * synapse organization (GO:0050808) | 2.99724951 |
99 | protein localization to cilium (GO:0061512) | 2.99241585 |
100 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 2.98888968 |
101 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 2.98888968 |
102 | regulation of female receptivity (GO:0045924) | 2.98424028 |
103 | epithelial cilium movement (GO:0003351) | 2.97665167 |
104 | mating behavior (GO:0007617) | 2.94502843 |
105 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.93020512 |
106 | regulation of neurotransmitter transport (GO:0051588) | 2.91830152 |
107 | membrane depolarization (GO:0051899) | 2.91773194 |
108 | negative regulation of sodium ion transport (GO:0010766) | 2.91747047 |
109 | neural tube formation (GO:0001841) | 2.91188790 |
110 | long term synaptic depression (GO:0060292) | 2.90613726 |
111 | fear response (GO:0042596) | 2.90562061 |
112 | ganglion development (GO:0061548) | 2.90266717 |
113 | regulation of neurotransmitter secretion (GO:0046928) | 2.90262898 |
114 | regulation of development, heterochronic (GO:0040034) | 2.90184213 |
115 | spinal cord development (GO:0021510) | 2.89570200 |
116 | cell migration in hindbrain (GO:0021535) | 2.89451925 |
117 | DNA damage response, detection of DNA damage (GO:0042769) | 2.87572874 |
118 | negative regulation of synaptic transmission (GO:0050805) | 2.87205970 |
119 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.86650276 |
120 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.86460784 |
121 | mitochondrion transport along microtubule (GO:0047497) | 2.86460784 |
122 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.86335257 |
123 | positive regulation of synaptic transmission (GO:0050806) | 2.86284294 |
124 | hippocampus development (GO:0021766) | 2.85222509 |
125 | regulation of dendritic spine development (GO:0060998) | 2.85118370 |
126 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.84460061 |
127 | synaptic transmission, dopaminergic (GO:0001963) | 2.83989949 |
128 | neuronal stem cell maintenance (GO:0097150) | 2.83838361 |
129 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.83511059 |
130 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.83325762 |
131 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.82777033 |
132 | detection of calcium ion (GO:0005513) | 2.81835735 |
133 | visual learning (GO:0008542) | 2.81814678 |
134 | * homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156) | 2.81552706 |
135 | somite development (GO:0061053) | 2.81437112 |
136 | auditory behavior (GO:0031223) | 2.77819480 |
137 | negative regulation of axon guidance (GO:1902668) | 2.75035062 |
138 | regulation of mitochondrial fission (GO:0090140) | 2.73372852 |
139 | short-term memory (GO:0007614) | 2.70295352 |
140 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger (GO:0007199 | 2.66116807 |
141 | paraxial mesoderm development (GO:0048339) | 2.64541824 |
142 | regulation of cilium movement (GO:0003352) | 2.64047665 |
143 | cilium morphogenesis (GO:0060271) | 2.61863041 |
144 | neuron migration (GO:0001764) | 2.60706178 |
145 | axon extension (GO:0048675) | 2.53973556 |
146 | cytoskeleton-dependent intracellular transport (GO:0030705) | 2.50994920 |
147 | appendage development (GO:0048736) | 2.50745483 |
148 | limb development (GO:0060173) | 2.50745483 |
149 | ephrin receptor signaling pathway (GO:0048013) | 2.50131921 |
150 | DNA integration (GO:0015074) | 2.48130357 |
151 | mechanosensory behavior (GO:0007638) | 2.47528886 |
152 | cilium assembly (GO:0042384) | 2.47305300 |
153 | negative chemotaxis (GO:0050919) | 2.46599469 |
154 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 2.46522524 |
155 | glycosphingolipid biosynthetic process (GO:0006688) | 2.45310606 |
156 | cilium organization (GO:0044782) | 2.44103399 |
157 | protein polyglutamylation (GO:0018095) | 2.42994929 |
158 | microtubule-based transport (GO:0010970) | 2.39259777 |
159 | response to auditory stimulus (GO:0010996) | 2.38977662 |
160 | sympathetic nervous system development (GO:0048485) | 2.38826392 |
161 | central nervous system neuron axonogenesis (GO:0021955) | 2.38430088 |
162 | neurofilament cytoskeleton organization (GO:0060052) | 2.38372160 |
163 | neuronal ion channel clustering (GO:0045161) | 2.37272829 |
164 | cerebral cortex cell migration (GO:0021795) | 2.34970537 |
165 | peptidyl-cysteine modification (GO:0018198) | 2.33030926 |
166 | cilium movement (GO:0003341) | 2.32747639 |
167 | regulation of synapse assembly (GO:0051963) | 2.32705107 |
168 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:004316 | 2.31906447 |
169 | regulation of timing of cell differentiation (GO:0048505) | 2.31072118 |
170 | regulation of oligodendrocyte differentiation (GO:0048713) | 2.30957803 |
171 | substrate-independent telencephalic tangential migration (GO:0021826) | 2.30345457 |
172 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 2.30345457 |
173 | neuromuscular synaptic transmission (GO:0007274) | 2.30342368 |
174 | * cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742) | 2.28081772 |
175 | synaptic transmission, cholinergic (GO:0007271) | 2.27809443 |
176 | * cell-cell adhesion (GO:0098609) | 2.27717467 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.02637624 |
2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.97529730 |
3 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.15123864 |
4 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.10156743 |
5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.06004124 |
6 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.65480123 |
7 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.65480123 |
8 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.64966655 |
9 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.64740080 |
10 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.59050937 |
11 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.56006649 |
12 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.49008795 |
13 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.48363790 |
14 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.45856248 |
15 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.40221100 |
16 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.35651387 |
17 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.32983892 |
18 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.27561453 |
19 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.25868019 |
20 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.17905102 |
21 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.16693888 |
22 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.12829130 |
23 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.08210111 |
24 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.07091968 |
25 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.06451513 |
26 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.04394641 |
27 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.03439597 |
28 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.02926685 |
29 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.96045444 |
30 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.91822734 |
31 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.90114296 |
32 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.88456039 |
33 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.85519816 |
34 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.80366490 |
35 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.77305870 |
36 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.75157041 |
37 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.74898014 |
38 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.73413976 |
39 | P300_19829295_ChIP-Seq_ESCs_Human | 1.73137981 |
40 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.71835023 |
41 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.70465244 |
42 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.69953867 |
43 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.69844914 |
44 | EWS_26573619_Chip-Seq_HEK293_Human | 1.69021859 |
45 | FUS_26573619_Chip-Seq_HEK293_Human | 1.68520245 |
46 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.66986478 |
47 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.66040459 |
48 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.65056112 |
49 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.62641349 |
50 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.59167106 |
51 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.58185545 |
52 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.57120926 |
53 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.55942667 |
54 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.54419137 |
55 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.53740903 |
56 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.53399461 |
57 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.52635990 |
58 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.48867693 |
59 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.48497828 |
60 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.48431699 |
61 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.47687704 |
62 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.45430844 |
63 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.44933681 |
64 | AR_25329375_ChIP-Seq_VCAP_Human | 1.42949972 |
65 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.42803073 |
66 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.42302851 |
67 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.40641559 |
68 | STAT3_23295773_ChIP-Seq_U87_Human | 1.36767250 |
69 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.31860949 |
70 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.31772879 |
71 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.31170460 |
72 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.28763571 |
73 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.26419957 |
74 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.24925146 |
75 | VDR_22108803_ChIP-Seq_LS180_Human | 1.24750155 |
76 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.24596603 |
77 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.23474745 |
78 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.23463312 |
79 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.22916295 |
80 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.22237175 |
81 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.21976441 |
82 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.21106781 |
83 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.20480444 |
84 | TP53_16413492_ChIP-PET_HCT116_Human | 1.20023020 |
85 | TCF4_23295773_ChIP-Seq_U87_Human | 1.18867519 |
86 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.18695017 |
87 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.18411527 |
88 | AR_19668381_ChIP-Seq_PC3_Human | 1.18095820 |
89 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.17452740 |
90 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.16733489 |
91 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.16480307 |
92 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.15573289 |
93 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.15343505 |
94 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.14450088 |
95 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.13771905 |
96 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.13610440 |
97 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.12646747 |
98 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.10953216 |
99 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.09618417 |
100 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.09618417 |
101 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.09076968 |
102 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.09029887 |
103 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.07628057 |
104 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.06913022 |
105 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.06147736 |
106 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.05893009 |
107 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.05765578 |
108 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.05765578 |
109 | JUN_21703547_ChIP-Seq_K562_Human | 1.05518272 |
110 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 1.05504494 |
111 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.05233636 |
112 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 1.04750928 |
113 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.04733843 |
114 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.04150829 |
115 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.03956106 |
116 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.03343553 |
117 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.02872148 |
118 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.02789204 |
119 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.02340085 |
120 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.01577147 |
121 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.01336701 |
122 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.01251027 |
123 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.01132222 |
124 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00614419 |
125 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.00559101 |
126 | POU5F1_18347094_ChIP-ChIP_MESCs_Mouse | 0.99505158 |
127 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.99269170 |
128 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.99236005 |
129 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.99093034 |
130 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.98925515 |
131 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.98688956 |
132 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.97655984 |
133 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.96838537 |
134 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.95690721 |
135 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.93773893 |
136 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.93057894 |
137 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.89691008 |
138 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.89617485 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004859_abnormal_synaptic_plasticity | 5.43965930 |
2 | MP0003880_abnormal_central_pattern | 4.84638800 |
3 | MP0003635_abnormal_synaptic_transmissio | 3.80613118 |
4 | MP0009745_abnormal_behavioral_response | 3.36507128 |
5 | MP0002063_abnormal_learning/memory/cond | 3.24757334 |
6 | MP0004270_analgesia | 3.06998819 |
7 | MP0002064_seizures | 3.01164417 |
8 | MP0009046_muscle_twitch | 2.93936372 |
9 | MP0001968_abnormal_touch/_nociception | 2.88938558 |
10 | MP0001486_abnormal_startle_reflex | 2.75985027 |
11 | MP0002572_abnormal_emotion/affect_behav | 2.69340906 |
12 | MP0002272_abnormal_nervous_system | 2.36833188 |
13 | MP0001440_abnormal_grooming_behavior | 2.33491530 |
14 | MP0002102_abnormal_ear_morphology | 2.29095937 |
15 | MP0002734_abnormal_mechanical_nocicepti | 2.23264453 |
16 | MP0009780_abnormal_chondrocyte_physiolo | 2.21545062 |
17 | MP0000778_abnormal_nervous_system | 2.20869344 |
18 | MP0004133_heterotaxia | 2.14651361 |
19 | MP0002184_abnormal_innervation | 2.07740233 |
20 | MP0002067_abnormal_sensory_capabilities | 2.06638623 |
21 | MP0001188_hyperpigmentation | 2.06286483 |
22 | MP0002736_abnormal_nociception_after | 1.99946055 |
23 | MP0005423_abnormal_somatic_nervous | 1.99642393 |
24 | MP0002653_abnormal_ependyma_morphology | 1.96252446 |
25 | MP0002735_abnormal_chemical_nociception | 1.92125782 |
26 | MP0000049_abnormal_middle_ear | 1.82961404 |
27 | MP0001501_abnormal_sleep_pattern | 1.76677731 |
28 | MP0002733_abnormal_thermal_nociception | 1.75957296 |
29 | MP0006292_abnormal_olfactory_placode | 1.75294482 |
30 | MP0002638_abnormal_pupillary_reflex | 1.70391153 |
31 | MP0002557_abnormal_social/conspecific_i | 1.69581799 |
32 | MP0002837_dystrophic_cardiac_calcinosis | 1.69223913 |
33 | MP0005646_abnormal_pituitary_gland | 1.66019992 |
34 | MP0001984_abnormal_olfaction | 1.65745891 |
35 | MP0001970_abnormal_pain_threshold | 1.64028580 |
36 | MP0003122_maternal_imprinting | 1.60200092 |
37 | MP0003329_amyloid_beta_deposits | 1.60143313 |
38 | MP0000955_abnormal_spinal_cord | 1.59756621 |
39 | MP0005386_behavior/neurological_phenoty | 1.58881869 |
40 | MP0004924_abnormal_behavior | 1.58881869 |
41 | MP0004811_abnormal_neuron_physiology | 1.53626605 |
42 | MP0003890_abnormal_embryonic-extraembry | 1.50999871 |
43 | MP0003136_yellow_coat_color | 1.50365707 |
44 | MP0008877_abnormal_DNA_methylation | 1.48319756 |
45 | MP0001293_anophthalmia | 1.47987127 |
46 | MP0002233_abnormal_nose_morphology | 1.46544909 |
47 | MP0005187_abnormal_penis_morphology | 1.45793877 |
48 | MP0003787_abnormal_imprinting | 1.44590275 |
49 | MP0002882_abnormal_neuron_morphology | 1.44587683 |
50 | MP0000566_synostosis | 1.44319013 |
51 | MP0003879_abnormal_hair_cell | 1.42717145 |
52 | MP0002876_abnormal_thyroid_physiology | 1.36808956 |
53 | MP0003119_abnormal_digestive_system | 1.36404742 |
54 | MP0003937_abnormal_limbs/digits/tail_de | 1.35975356 |
55 | MP0004858_abnormal_nervous_system | 1.35137991 |
56 | MP0005551_abnormal_eye_electrophysiolog | 1.34875032 |
57 | MP0008569_lethality_at_weaning | 1.33727180 |
58 | MP0001905_abnormal_dopamine_level | 1.32086987 |
59 | MP0000631_abnormal_neuroendocrine_gland | 1.31688657 |
60 | MP0006276_abnormal_autonomic_nervous | 1.31661489 |
61 | MP0002066_abnormal_motor_capabilities/c | 1.30276795 |
62 | MP0001986_abnormal_taste_sensitivity | 1.29733493 |
63 | MP0002938_white_spotting | 1.27153426 |
64 | MP0010386_abnormal_urinary_bladder | 1.23151337 |
65 | MP0001502_abnormal_circadian_rhythm | 1.22996830 |
66 | MP0001529_abnormal_vocalization | 1.22840426 |
67 | MP0005171_absent_coat_pigmentation | 1.19537023 |
68 | MP0004885_abnormal_endolymph | 1.16741435 |
69 | MP0002234_abnormal_pharynx_morphology | 1.15746118 |
70 | MP0004142_abnormal_muscle_tone | 1.15235156 |
71 | MP0000026_abnormal_inner_ear | 1.15187068 |
72 | MP0002152_abnormal_brain_morphology | 1.15103772 |
73 | MP0003567_abnormal_fetal_cardiomyocyte | 1.14631223 |
74 | MP0002909_abnormal_adrenal_gland | 1.14434682 |
75 | MP0001286_abnormal_eye_development | 1.14205078 |
76 | MP0000647_abnormal_sebaceous_gland | 1.13848602 |
77 | MP0002697_abnormal_eye_size | 1.12553629 |
78 | MP0004742_abnormal_vestibular_system | 1.11814173 |
79 | MP0003755_abnormal_palate_morphology | 1.06964870 |
80 | MP0005391_vision/eye_phenotype | 1.05284693 |
81 | MP0000751_myopathy | 1.05160544 |
82 | MP0003633_abnormal_nervous_system | 1.03422995 |
83 | MP0001177_atelectasis | 1.02898258 |
84 | MP0001299_abnormal_eye_distance/ | 1.01343117 |
85 | MP0002090_abnormal_vision | 1.01138211 |
86 | MP0006072_abnormal_retinal_apoptosis | 1.00476571 |
87 | MP0002822_catalepsy | 0.98398421 |
88 | MP0003634_abnormal_glial_cell | 0.98088356 |
89 | MP0005394_taste/olfaction_phenotype | 0.96866666 |
90 | MP0005499_abnormal_olfactory_system | 0.96866666 |
91 | MP0008872_abnormal_physiological_respon | 0.96447412 |
92 | MP0003631_nervous_system_phenotype | 0.95686119 |
93 | MP0005195_abnormal_posterior_eye | 0.91578637 |
94 | MP0000537_abnormal_urethra_morphology | 0.90890992 |
95 | MP0001963_abnormal_hearing_physiology | 0.88811051 |
96 | MP0005623_abnormal_meninges_morphology | 0.88755949 |
97 | MP0002752_abnormal_somatic_nervous | 0.87942618 |
98 | MP0002229_neurodegeneration | 0.86199823 |
99 | MP0002081_perinatal_lethality | 0.81427888 |
100 | MP0005248_abnormal_Harderian_gland | 0.81180400 |
101 | MP0004145_abnormal_muscle_electrophysio | 0.80948374 |
102 | MP0002069_abnormal_eating/drinking_beha | 0.80603887 |
103 | MP0003011_delayed_dark_adaptation | 0.80499399 |
104 | MP0004233_abnormal_muscle_weight | 0.80415113 |
105 | MP0003221_abnormal_cardiomyocyte_apopto | 0.79078770 |
106 | MP0002751_abnormal_autonomic_nervous | 0.76992027 |
107 | MP0003942_abnormal_urinary_system | 0.76173986 |
108 | MP0004484_altered_response_of | 0.75500000 |
109 | MP0004215_abnormal_myocardial_fiber | 0.74213531 |
110 | MP0003632_abnormal_nervous_system | 0.73579213 |
111 | MP0009250_abnormal_appendicular_skeleto | 0.73408759 |
112 | MP0002092_abnormal_eye_morphology | 0.73388883 |
113 | MP0002116_abnormal_craniofacial_bone | 0.73227685 |
114 | MP0003137_abnormal_impulse_conducting | 0.72404753 |
115 | MP0003938_abnormal_ear_development | 0.71756445 |
116 | MP0003935_abnormal_craniofacial_develop | 0.71266227 |
117 | MP0004085_abnormal_heartbeat | 0.70255104 |
118 | MP0001485_abnormal_pinna_reflex | 0.70055723 |
119 | MP0005645_abnormal_hypothalamus_physiol | 0.69951291 |
120 | MP0003283_abnormal_digestive_organ | 0.69758899 |
121 | MP0003121_genomic_imprinting | 0.69539457 |
122 | MP0000920_abnormal_myelination | 0.69486409 |
123 | MP0003861_abnormal_nervous_system | 0.69418069 |
124 | MP0002084_abnormal_developmental_patter | 0.68383883 |
125 | MP0005409_darkened_coat_color | 0.68379736 |
126 | MP0001943_abnormal_respiration | 0.67851126 |
127 | MP0003385_abnormal_body_wall | 0.67703922 |
128 | MP0008789_abnormal_olfactory_epithelium | 0.64188801 |
129 | MP0010030_abnormal_orbit_morphology | 0.64002008 |
130 | MP0000534_abnormal_ureter_morphology | 0.63784318 |
131 | MP0000013_abnormal_adipose_tissue | 0.62624384 |
132 | MP0005253_abnormal_eye_physiology | 0.62538573 |
133 | MP0000681_abnormal_thyroid_gland | 0.60579994 |
134 | MP0004134_abnormal_chest_morphology | 0.59131419 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Focal motor seizures (HP:0011153) | 7.93669798 |
2 | Hyperventilation (HP:0002883) | 5.33758921 |
3 | Focal seizures (HP:0007359) | 5.24643689 |
4 | Atonic seizures (HP:0010819) | 5.12070847 |
5 | Epileptic encephalopathy (HP:0200134) | 5.01225339 |
6 | Absence seizures (HP:0002121) | 4.59845263 |
7 | Febrile seizures (HP:0002373) | 4.50660890 |
8 | Dialeptic seizures (HP:0011146) | 4.10727354 |
9 | Myokymia (HP:0002411) | 3.95493135 |
10 | Visual hallucinations (HP:0002367) | 3.86598411 |
11 | Broad-based gait (HP:0002136) | 3.84792888 |
12 | Progressive cerebellar ataxia (HP:0002073) | 3.76041253 |
13 | Generalized tonic-clonic seizures (HP:0002069) | 3.67977814 |
14 | Cortical dysplasia (HP:0002539) | 3.56960893 |
15 | Excessive salivation (HP:0003781) | 3.28155814 |
16 | Drooling (HP:0002307) | 3.28155814 |
17 | Poor eye contact (HP:0000817) | 3.09948674 |
18 | Epileptiform EEG discharges (HP:0011182) | 3.07964267 |
19 | Truncal ataxia (HP:0002078) | 2.99672282 |
20 | Lissencephaly (HP:0001339) | 2.95744348 |
21 | Progressive inability to walk (HP:0002505) | 2.90733551 |
22 | Abnormal social behavior (HP:0012433) | 2.90613320 |
23 | Impaired social interactions (HP:0000735) | 2.90613320 |
24 | Absent speech (HP:0001344) | 2.87631743 |
25 | True hermaphroditism (HP:0010459) | 2.86481093 |
26 | EEG with generalized epileptiform discharges (HP:0011198) | 2.80687508 |
27 | Aqueductal stenosis (HP:0002410) | 2.79549303 |
28 | Scanning speech (HP:0002168) | 2.79007615 |
29 | Gaze-evoked nystagmus (HP:0000640) | 2.77961399 |
30 | Termporal pattern (HP:0011008) | 2.77782369 |
31 | Insidious onset (HP:0003587) | 2.77782369 |
32 | Hepatoblastoma (HP:0002884) | 2.77122722 |
33 | Amblyopia (HP:0000646) | 2.73718469 |
34 | Mutism (HP:0002300) | 2.65604834 |
35 | Hypsarrhythmia (HP:0002521) | 2.61971523 |
36 | Supranuclear gaze palsy (HP:0000605) | 2.60628208 |
37 | Genetic anticipation (HP:0003743) | 2.60334015 |
38 | Pancreatic cysts (HP:0001737) | 2.59908448 |
39 | Cerebral inclusion bodies (HP:0100314) | 2.59058390 |
40 | Pancreatic fibrosis (HP:0100732) | 2.58901969 |
41 | Dysdiadochokinesis (HP:0002075) | 2.58097148 |
42 | Molar tooth sign on MRI (HP:0002419) | 2.50625435 |
43 | Abnormality of midbrain morphology (HP:0002418) | 2.50625435 |
44 | Hyperglycinemia (HP:0002154) | 2.50533570 |
45 | Inability to walk (HP:0002540) | 2.47968271 |
46 | Septo-optic dysplasia (HP:0100842) | 2.47050435 |
47 | Hyperthyroidism (HP:0000836) | 2.46972486 |
48 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.46163976 |
49 | Occipital encephalocele (HP:0002085) | 2.45581941 |
50 | Hypoplasia of the brainstem (HP:0002365) | 2.45372216 |
51 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 2.45372216 |
52 | Protruding tongue (HP:0010808) | 2.44187197 |
53 | Chronic hepatic failure (HP:0100626) | 2.42758716 |
54 | Nephronophthisis (HP:0000090) | 2.42043119 |
55 | Gait imbalance (HP:0002141) | 2.41356843 |
56 | Diplopia (HP:0000651) | 2.40770744 |
57 | Abnormality of binocular vision (HP:0011514) | 2.40770744 |
58 | Broad foot (HP:0001769) | 2.39685326 |
59 | Vitreoretinal degeneration (HP:0000655) | 2.39522042 |
60 | Optic nerve hypoplasia (HP:0000609) | 2.38405462 |
61 | Depression (HP:0000716) | 2.38131057 |
62 | Poor coordination (HP:0002370) | 2.36931073 |
63 | Action tremor (HP:0002345) | 2.36815783 |
64 | Dysmetria (HP:0001310) | 2.36354818 |
65 | Neurofibrillary tangles (HP:0002185) | 2.36134354 |
66 | Postaxial hand polydactyly (HP:0001162) | 2.35184806 |
67 | Thickened helices (HP:0000391) | 2.32930639 |
68 | Pachygyria (HP:0001302) | 2.30205642 |
69 | Pheochromocytoma (HP:0002666) | 2.29804547 |
70 | Hypoventilation (HP:0002791) | 2.28987632 |
71 | Limb dystonia (HP:0002451) | 2.28095433 |
72 | Abnormality of salivation (HP:0100755) | 2.27564416 |
73 | Hemiparesis (HP:0001269) | 2.22221561 |
74 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.21915473 |
75 | Abnormality of the corticospinal tract (HP:0002492) | 2.19554136 |
76 | Renal hypoplasia (HP:0000089) | 2.18692769 |
77 | Blue irides (HP:0000635) | 2.18420657 |
78 | Buphthalmos (HP:0000557) | 2.18058252 |
79 | Abnormal eating behavior (HP:0100738) | 2.16552781 |
80 | Intestinal atresia (HP:0011100) | 2.15593878 |
81 | Anxiety (HP:0000739) | 2.14639018 |
82 | Anophthalmia (HP:0000528) | 2.14019613 |
83 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.13717287 |
84 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.13717287 |
85 | Stereotypic behavior (HP:0000733) | 2.12742722 |
86 | Amyotrophic lateral sclerosis (HP:0007354) | 2.12318170 |
87 | Type II lissencephaly (HP:0007260) | 2.11223295 |
88 | Agitation (HP:0000713) | 2.09926714 |
89 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 2.07668601 |
90 | Postural instability (HP:0002172) | 2.07599410 |
91 | Decreased testicular size (HP:0008734) | 2.07276083 |
92 | Shoulder girdle muscle weakness (HP:0003547) | 2.06217849 |
93 | Fetal akinesia sequence (HP:0001989) | 2.03073937 |
94 | Failure to thrive in infancy (HP:0001531) | 2.02061126 |
95 | Impaired smooth pursuit (HP:0007772) | 2.01707154 |
96 | Micropenis (HP:0000054) | 2.01507255 |
97 | Split foot (HP:0001839) | 1.99230993 |
98 | Narrow forehead (HP:0000341) | 1.98902573 |
99 | Congenital primary aphakia (HP:0007707) | 1.97839764 |
100 | Lower limb muscle weakness (HP:0007340) | 1.95470191 |
101 | Urinary urgency (HP:0000012) | 1.95455737 |
102 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.95435773 |
103 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.95435773 |
104 | Rib fusion (HP:0000902) | 1.94952409 |
105 | Abnormality of the renal medulla (HP:0100957) | 1.94788355 |
106 | Colon cancer (HP:0003003) | 1.94534221 |
107 | Anencephaly (HP:0002323) | 1.94367510 |
108 | Cutaneous finger syndactyly (HP:0010554) | 1.93848279 |
109 | Postaxial foot polydactyly (HP:0001830) | 1.93247247 |
110 | Generalized myoclonic seizures (HP:0002123) | 1.92606421 |
111 | Intention tremor (HP:0002080) | 1.91988674 |
112 | Medial flaring of the eyebrow (HP:0010747) | 1.91732896 |
113 | Sclerocornea (HP:0000647) | 1.90515803 |
114 | Hemivertebrae (HP:0002937) | 1.90497005 |
115 | Polyphagia (HP:0002591) | 1.89327534 |
116 | Hypoplastic pelvis (HP:0008839) | 1.88450089 |
117 | Clumsiness (HP:0002312) | 1.87672287 |
118 | Oligodactyly (hands) (HP:0001180) | 1.87611940 |
119 | Ankle clonus (HP:0011448) | 1.87141123 |
120 | Gait ataxia (HP:0002066) | 1.86482065 |
121 | Inappropriate behavior (HP:0000719) | 1.85486313 |
122 | Akinesia (HP:0002304) | 1.85279477 |
123 | Polymicrogyria (HP:0002126) | 1.84196852 |
124 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.83611543 |
125 | Bradykinesia (HP:0002067) | 1.83487719 |
126 | Annular pancreas (HP:0001734) | 1.82655772 |
127 | Preaxial hand polydactyly (HP:0001177) | 1.82296294 |
128 | Abnormality of the labia minora (HP:0012880) | 1.82133004 |
129 | Spastic gait (HP:0002064) | 1.82044830 |
130 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.80826124 |
131 | Thyroid-stimulating hormone excess (HP:0002925) | 1.80595058 |
132 | Abnormality of macular pigmentation (HP:0008002) | 1.80355928 |
133 | Neuroendocrine neoplasm (HP:0100634) | 1.80234295 |
134 | Retinal dysplasia (HP:0007973) | 1.80223229 |
135 | Labial hypoplasia (HP:0000066) | 1.79951711 |
136 | Spastic tetraplegia (HP:0002510) | 1.79385330 |
137 | Lower limb asymmetry (HP:0100559) | 1.78620395 |
138 | Bifid tongue (HP:0010297) | 1.78448550 |
139 | High anterior hairline (HP:0009890) | 1.77597872 |
140 | Deep palmar crease (HP:0006191) | 1.77166170 |
141 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.76988145 |
142 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.76827121 |
143 | Narrow nasal bridge (HP:0000446) | 1.76666582 |
144 | Specific learning disability (HP:0001328) | 1.76294808 |
145 | Generalized hypotonia (HP:0001290) | 1.76100366 |
146 | Open mouth (HP:0000194) | 1.76052714 |
147 | Meningocele (HP:0002435) | 1.75567336 |
148 | Resting tremor (HP:0002322) | 1.74278100 |
149 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.73856206 |
150 | Genital tract atresia (HP:0001827) | 1.73802182 |
151 | Vaginal atresia (HP:0000148) | 1.73725342 |
152 | Nephrogenic diabetes insipidus (HP:0009806) | 1.73720319 |
153 | Dandy-Walker malformation (HP:0001305) | 1.73470136 |
154 | Scrotal hypoplasia (HP:0000046) | 1.73303799 |
155 | Cutaneous syndactyly (HP:0012725) | 1.73087467 |
156 | Autism (HP:0000717) | 1.72649739 |
157 | Exotropia (HP:0000577) | 1.72147942 |
158 | Cystic liver disease (HP:0006706) | 1.72125534 |
159 | Short foot (HP:0001773) | 1.71611228 |
160 | Lower limb amyotrophy (HP:0007210) | 1.71275053 |
161 | Abnormality of the lower motor neuron (HP:0002366) | 1.71234501 |
162 | Status epilepticus (HP:0002133) | 1.71204183 |
163 | Anosmia (HP:0000458) | 1.70851032 |
164 | Tubulointerstitial nephritis (HP:0001970) | 1.69776558 |
165 | Morphological abnormality of the middle ear (HP:0008609) | 1.69109652 |
166 | Oligodactyly (HP:0012165) | 1.68686712 |
167 | Chorioretinal coloboma (HP:0000567) | 1.66413878 |
168 | Renal dysplasia (HP:0000110) | 1.66378034 |
169 | Absent septum pellucidum (HP:0001331) | 1.65151132 |
170 | Abnormality of glycine metabolism (HP:0010895) | 1.65123274 |
171 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.65123274 |
172 | Myelomeningocele (HP:0002475) | 1.64605349 |
173 | Abnormality of the intervertebral disk (HP:0005108) | 1.64151745 |
174 | Patellar aplasia (HP:0006443) | 1.63658675 |
175 | Short tibia (HP:0005736) | 1.63157447 |
176 | Cerebellar dysplasia (HP:0007033) | 1.63129746 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EPHA4 | 4.12823671 |
2 | NTRK3 | 3.96128567 |
3 | CASK | 3.93023859 |
4 | MARK1 | 3.24535747 |
5 | TRIM28 | 3.18856966 |
6 | MAP3K4 | 2.91013228 |
7 | PLK2 | 2.87367035 |
8 | MAP3K9 | 2.74066950 |
9 | MAP2K7 | 2.54861549 |
10 | DYRK2 | 2.45139672 |
11 | MINK1 | 2.40821378 |
12 | EPHA3 | 2.32591766 |
13 | NTRK2 | 2.24620521 |
14 | SRPK1 | 2.16609607 |
15 | MAP4K2 | 2.16452155 |
16 | TNIK | 2.01712371 |
17 | KSR1 | 2.00004632 |
18 | PAK6 | 1.97821812 |
19 | ERBB3 | 1.97216031 |
20 | CSNK1G3 | 1.94785902 |
21 | CSNK1A1L | 1.84338695 |
22 | AKT3 | 1.83189938 |
23 | CSNK1G1 | 1.73617407 |
24 | CCNB1 | 1.73559783 |
25 | PINK1 | 1.71995065 |
26 | DYRK3 | 1.70645021 |
27 | MAP3K12 | 1.70193145 |
28 | SIK2 | 1.58455738 |
29 | KSR2 | 1.58203217 |
30 | DAPK2 | 1.50577252 |
31 | MAPK13 | 1.50331538 |
32 | EPHB2 | 1.48993055 |
33 | PNCK | 1.44568514 |
34 | MAP2K4 | 1.43974309 |
35 | CDK5 | 1.43352355 |
36 | NTRK1 | 1.39439065 |
37 | BCKDK | 1.34648999 |
38 | PRKCG | 1.31717348 |
39 | DAPK1 | 1.31312882 |
40 | MKNK1 | 1.29070627 |
41 | DYRK1B | 1.29003790 |
42 | RIPK4 | 1.24274834 |
43 | PAK3 | 1.21825632 |
44 | FGFR2 | 1.21783635 |
45 | GRK5 | 1.17646685 |
46 | CAMK2A | 1.15826234 |
47 | RPS6KA4 | 1.15510715 |
48 | STK38L | 1.14230753 |
49 | LATS2 | 1.13376237 |
50 | CAMKK2 | 1.11170621 |
51 | PHKG2 | 1.10549358 |
52 | PHKG1 | 1.10549358 |
53 | CAMKK1 | 1.08754037 |
54 | BMPR2 | 1.07767908 |
55 | ARAF | 1.04090900 |
56 | FES | 1.00302348 |
57 | MKNK2 | 0.99603472 |
58 | CDK19 | 0.98095897 |
59 | CDK14 | 0.96573471 |
60 | CAMK2B | 0.93087636 |
61 | MAP3K2 | 0.93028528 |
62 | UHMK1 | 0.92534996 |
63 | FER | 0.92369917 |
64 | CDK18 | 0.92186486 |
65 | PRKCE | 0.91248376 |
66 | LIMK1 | 0.91202492 |
67 | SGK494 | 0.90621435 |
68 | SGK223 | 0.90621435 |
69 | PTK2B | 0.90499678 |
70 | BCR | 0.88735288 |
71 | SGK2 | 0.87486780 |
72 | PRPF4B | 0.87173663 |
73 | CDK15 | 0.86155379 |
74 | NEK1 | 0.84017709 |
75 | OXSR1 | 0.80032209 |
76 | DDR2 | 0.78562060 |
77 | RET | 0.77734748 |
78 | WNK3 | 0.77283331 |
79 | SIK3 | 0.75555520 |
80 | ADRBK2 | 0.75068135 |
81 | TSSK6 | 0.71352261 |
82 | CDK11A | 0.70158752 |
83 | ROCK2 | 0.69767529 |
84 | RAF1 | 0.69017532 |
85 | CSNK1G2 | 0.68328569 |
86 | PKN1 | 0.66840413 |
87 | SGK1 | 0.65158996 |
88 | NUAK1 | 0.64679208 |
89 | FGR | 0.64269442 |
90 | TIE1 | 0.59810164 |
91 | MAP2K1 | 0.59175151 |
92 | GRK1 | 0.58897823 |
93 | PRKCZ | 0.58733192 |
94 | TYRO3 | 0.58092431 |
95 | MAP3K6 | 0.57892316 |
96 | ROCK1 | 0.56802193 |
97 | DYRK1A | 0.56013033 |
98 | SGK3 | 0.55901661 |
99 | FRK | 0.55555014 |
100 | PLK3 | 0.55093738 |
101 | BRD4 | 0.52851610 |
102 | LMTK2 | 0.52633941 |
103 | CAMK2G | 0.52533661 |
104 | STK11 | 0.51738357 |
105 | MUSK | 0.50950205 |
106 | FYN | 0.50775626 |
107 | CAMK2D | 0.49515636 |
108 | BRAF | 0.49080592 |
109 | PRKD3 | 0.48781976 |
110 | PIK3CA | 0.48121489 |
111 | LATS1 | 0.48058950 |
112 | PRKCH | 0.47504784 |
113 | ERBB2 | 0.47107199 |
114 | VRK1 | 0.46691612 |
115 | PLK1 | 0.46300818 |
116 | ZAK | 0.46129236 |
117 | CSNK1A1 | 0.45710402 |
118 | CDC42BPA | 0.45590646 |
119 | RPS6KA3 | 0.45546642 |
120 | CSNK1D | 0.44425014 |
121 | WNK4 | 0.44330192 |
122 | MAPK15 | 0.43788668 |
123 | ADRBK1 | 0.43326228 |
124 | MARK2 | 0.40563143 |
125 | MAP3K5 | 0.40457726 |
126 | PRKAA1 | 0.39866554 |
127 | DMPK | 0.39495937 |
128 | MAP3K13 | 0.39463697 |
129 | CSNK1E | 0.38313096 |
130 | MAPK10 | 0.38279185 |
131 | PRKCB | 0.38211928 |
132 | PRKG1 | 0.37399240 |
133 | STK16 | 0.37316938 |
134 | BMPR1B | 0.35372035 |
135 | FGFR1 | 0.34813451 |
136 | NEK6 | 0.33996355 |
137 | PRKACA | 0.33274828 |
138 | CAMK1 | 0.33249361 |
139 | MAPK9 | 0.32939010 |
140 | EPHB1 | 0.32850348 |
141 | MYLK | 0.32729442 |
142 | CAMK4 | 0.32573438 |
143 | INSRR | 0.32507288 |
144 | PRKACB | 0.31957978 |
145 | RPS6KA5 | 0.31717154 |
146 | PLK4 | 0.28717196 |
147 | TESK1 | 0.27302922 |
148 | PRKDC | 0.26654672 |
149 | ATM | 0.24583329 |
150 | CDK3 | 0.23765611 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.88649769 |
2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.02962793 |
3 | GABAergic synapse_Homo sapiens_hsa04727 | 2.82087841 |
4 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.73567112 |
5 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.63011802 |
6 | Long-term potentiation_Homo sapiens_hsa04720 | 2.62880239 |
7 | Circadian entrainment_Homo sapiens_hsa04713 | 2.59513703 |
8 | Morphine addiction_Homo sapiens_hsa05032 | 2.49165384 |
9 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.45699854 |
10 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.34942775 |
11 | Protein export_Homo sapiens_hsa03060 | 2.33311324 |
12 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.18503517 |
13 | Olfactory transduction_Homo sapiens_hsa04740 | 2.18272290 |
14 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.17862300 |
15 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.09635976 |
16 | Salivary secretion_Homo sapiens_hsa04970 | 2.02078015 |
17 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.99768996 |
18 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.92477298 |
19 | Long-term depression_Homo sapiens_hsa04730 | 1.86826569 |
20 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.86655282 |
21 | Taste transduction_Homo sapiens_hsa04742 | 1.83783807 |
22 | Renin secretion_Homo sapiens_hsa04924 | 1.80616354 |
23 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.79859843 |
24 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.79091701 |
25 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.76865107 |
26 | Insulin secretion_Homo sapiens_hsa04911 | 1.66022790 |
27 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.63970436 |
28 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.63495323 |
29 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.63036688 |
30 | Basal transcription factors_Homo sapiens_hsa03022 | 1.62487014 |
31 | Parkinsons disease_Homo sapiens_hsa05012 | 1.59920696 |
32 | Phototransduction_Homo sapiens_hsa04744 | 1.57932775 |
33 | Cocaine addiction_Homo sapiens_hsa05030 | 1.57863645 |
34 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.57549301 |
35 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.57428571 |
36 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.53775285 |
37 | Axon guidance_Homo sapiens_hsa04360 | 1.53001437 |
38 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.48235582 |
39 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.47000918 |
40 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.46542372 |
41 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.44060077 |
42 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.43982744 |
43 | Gap junction_Homo sapiens_hsa04540 | 1.41461148 |
44 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.41057463 |
45 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.39284379 |
46 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.36245504 |
47 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.33465784 |
48 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.26402724 |
49 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.24826984 |
50 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.21304501 |
51 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.18762711 |
52 | Glioma_Homo sapiens_hsa05214 | 1.16529016 |
53 | Huntingtons disease_Homo sapiens_hsa05016 | 1.15874815 |
54 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.13878032 |
55 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.12876009 |
56 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.10870189 |
57 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.08651352 |
58 | Melanogenesis_Homo sapiens_hsa04916 | 1.07028211 |
59 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.06558126 |
60 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.99762514 |
61 | RNA polymerase_Homo sapiens_hsa03020 | 0.96692924 |
62 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.95908442 |
63 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.95795734 |
64 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.95615574 |
65 | RNA degradation_Homo sapiens_hsa03018 | 0.94743778 |
66 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.94050862 |
67 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.93265699 |
68 | Spliceosome_Homo sapiens_hsa03040 | 0.92788566 |
69 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.89846415 |
70 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.89603830 |
71 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.88732615 |
72 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.88086514 |
73 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.87835583 |
74 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.87752161 |
75 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.87549453 |
76 | RNA transport_Homo sapiens_hsa03013 | 0.84741067 |
77 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.84221868 |
78 | Peroxisome_Homo sapiens_hsa04146 | 0.83584364 |
79 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.82169128 |
80 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.80557317 |
81 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.80023082 |
82 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.79975522 |
83 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.77968512 |
84 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.77732738 |
85 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.76742487 |
86 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.75978014 |
87 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.75533025 |
88 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.75162114 |
89 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.74340269 |
90 | Tight junction_Homo sapiens_hsa04530 | 0.74163194 |
91 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.73877124 |
92 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.73365306 |
93 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.69799669 |
94 | Base excision repair_Homo sapiens_hsa03410 | 0.69337853 |
95 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.69067435 |
96 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.68824269 |
97 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.68618041 |
98 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.68328333 |
99 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.66800564 |
100 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.66760312 |
101 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.66299989 |
102 | Alzheimers disease_Homo sapiens_hsa05010 | 0.65436651 |
103 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.64001064 |
104 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.62310098 |
105 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.62049349 |
106 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.62047759 |
107 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.59498314 |
108 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.58797020 |
109 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.57465810 |
110 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.57161191 |
111 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.55986638 |
112 | Alcoholism_Homo sapiens_hsa05034 | 0.55963241 |
113 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.55906944 |
114 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.54460100 |
115 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.54343484 |
116 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.53771602 |
117 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.53339397 |
118 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.52452472 |
119 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.52444984 |
120 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.51860284 |
121 | Endometrial cancer_Homo sapiens_hsa05213 | 0.51622256 |
122 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.51411019 |
123 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.51001723 |
124 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.50648426 |
125 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.50605563 |
126 | Metabolic pathways_Homo sapiens_hsa01100 | 0.49214183 |
127 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.49075186 |
128 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.48332973 |
129 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.48241936 |
130 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.46391777 |
131 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.46247118 |
132 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.46008765 |
133 | Carbon metabolism_Homo sapiens_hsa01200 | 0.45847500 |
134 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.45495728 |
135 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.44983479 |
136 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.44648713 |
137 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.44360597 |
138 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.43706655 |
139 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.43238663 |
140 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.42727802 |
141 | Melanoma_Homo sapiens_hsa05218 | 0.42171074 |
142 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.40034985 |
143 | Phagosome_Homo sapiens_hsa04145 | 0.39326701 |
144 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.39252185 |
145 | Adherens junction_Homo sapiens_hsa04520 | 0.37641143 |
146 | Colorectal cancer_Homo sapiens_hsa05210 | 0.37040830 |
147 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.35720490 |
148 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.35533369 |
149 | Prion diseases_Homo sapiens_hsa05020 | 0.35188235 |
150 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.34791628 |
151 | Circadian rhythm_Homo sapiens_hsa04710 | 0.31042896 |
152 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.30994798 |
153 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.30403151 |
154 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.29511310 |
155 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.25475500 |